Market closedNon-fractional
Sana Biotechnology/SANA
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX
About Sana Biotechnology
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others.
Ticker
SANA
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
Seattle, United States
Employees
328
Website
www.sana.com
SANA Metrics
BasicAdvanced
$1.2B
Market cap
-
P/E ratio
-$1.53
EPS
1.62
Beta
-
Dividend rate
Price and volume
Market cap
$1.2B
Beta
1.62
Financial strength
Current ratio
6.073
Quick ratio
5.88
Long term debt to equity
24.77
Total debt to equity
28.28
Management effectiveness
Return on assets (TTM)
-30.95%
Return on equity (TTM)
-76.82%
Valuation
Price to book
3.15
Price to tangible book (TTM)
6.74
Price to free cash flow (TTM)
-3.93
Growth
Earnings per share change (TTM)
-9.07%
3-year earnings per share growth
-47.82%
What the Analysts think about SANA
Analyst Ratings
Majority rating from 7 analysts.
SANA Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$107M
21.91%
Profit margin
0.00%
NaN%
SANA Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.59
$0.02
-$0.41
-$0.32
-
Expected
-$0.43
-$0.45
-$0.38
-$0.32
-$0.29
Surprise
38.28%
-104.48%
7.89%
0.63%
-
SANA News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sana Biotechnology stock?
Sana Biotechnology (SANA) has a market cap of $1.2B as of July 05, 2024.
What is the P/E ratio for Sana Biotechnology stock?
The price to earnings (P/E) ratio for Sana Biotechnology (SANA) stock is 0 as of July 05, 2024.
Does Sana Biotechnology stock pay dividends?
No, Sana Biotechnology (SANA) stock does not pay dividends to its shareholders as of July 05, 2024.
When is the next Sana Biotechnology dividend payment date?
Sana Biotechnology (SANA) stock does not pay dividends to its shareholders.
What is the beta indicator for Sana Biotechnology?
Sana Biotechnology (SANA) has a beta rating of 1.62. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Sana Biotechnology stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.